Introduction In vivo animal models for Mast cell research: 1.Guinea Pig 2.Humanized Mice 3.Zebrafish Aim: comparison of established versus new in vivo.

Slides:



Advertisements
Similar presentations
Areas of Research Specific issues. Clinical Trials Phase I First use in humans of an experimental drug or treatment In a small group of healthy volunteers.
Advertisements

José Pedro Lopes Exhausted CD3 CD8 TCR TIM3 1B11 LAG3 Generated in chronic antigen- mediated TCR stimulation. Express inhibitory receptors and lack effector.
Group 6 In vitro models for rodent mast cells Trainer: Ronit Sagi-Eisenberg Marek Grosicki Carl-Fredrik Johnzon Ahlam Barhoum Nicole Meyer Luca Danelli.
Younas Masih RN, Post RN BSc.N (Lecturer ) New Life College Of Nursing Karachi 11/7/20141Antimicrobial medications.
Page 1 1 FDA Advisory Committee Meeting “Safety Considerations in the Development of Ultrasound Contrast Agents” June 24, 2008 Nonclinical Development.
Models for in vivo and in vitro studies on basophils
09-Sep-2003 Predicting human risk with animal research: lessons learned from caffeine/ephedrine combinations Richard J. Briscoe, Ph.D. Safety Pharmacology.
Introduction to Research Methodology
Cytokines Slackers Facts by Mike Ori. Disclaimer The information represents my understanding only so errors and omissions are probably rampant. It has.
Allergy and Hypersensitivity K. J. Goodrum Types of Immune Hypersensitivity Reactions.
Discussion Our current results suggest that it is possible to identify susceptibility regions using this methodology. The presented method takes advantage.
Principles of Immunology Cells of the Immune System 1/26/06 “Those who have health, have hope. Those who have hope have everything.” Arabian proverb.
TNF superfamily TNF: produced by macrophages, monocytes, lymphocytes, fibroblasts upon inflammation, infection, injury, environmental challenges.
Delivery Of Proteins: Target Site-specific Delivery By The Parenteral Route Saeb Aliwaini1.
Immunity 6.5 Antibodies.
Cellular Therapies for Cardiac Diseases – FDA Preclinical Perspective Richard D. McFarland Ph.D., M.D. CBER/OCTGT/DCEPT BRMAC # 37 March 18-19, 2004.
Hypersensitivity Disorders. Immune ResponseDisease Example IgERagweed hay fever IgG CytotoxicHemolytic anemia Immune complexSerum sickness T CellPoison.
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
Cytokines Department of Microbiology. Important terms Cytokines: Proteinaceous messenger molecules of low molecular weight (usually of less than 30kDa),
Introduction to Lab Ex. 24: Hypersensitivity. Response to antigens (allergens) leading to damage Require sensitizing dose(s) Introduction to Lab Ex. 24:
Allergenicity assessment of genetically modified organisms (GMOs )
Nonclinical Perspective on Initiating Phase 1 Studies for Small Molecular Weight Compounds John K. Leighton, PH.D., DABT Supervisory Pharmacologist Division.
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) in Non-Small Cell Lung Cancer (NSCLC) Victor.
Abstract  Objectives: We wish to determine the efficacy and mechanism of action of Sophora flavesence alkaloids mediated inhibition of airway constriction.
Hypersensitivity reactions. Overview Hypersensitivity, allergic reaction –similar to protective mechanisms –exaggerated and damaging to host Antigens.
Mouse models in Immunology
Overview of Immunology Organs and tissues Cells Molecules Components of IS Functions of IS Pathology of IR * IS: Immune system IR: Immune response Applications.
IMMUNE SYSTEM OVERVIEW
MAIN TOXICITY TESTING. TESTING STRATEGIES A number of different types of data are used in order to establish the safety of chemical substances for use.
Cytokines Basic introduction. Contents Definition General characteristics Types of cytokines Cytokine receptors and their types Biological functions of.
Critical Role of TH Cells in Specific Immunity
Myelopoiesis and Lymphopoiesis Amy Lovett-Racke, PhD Associate Professor Department of Microbial Infection and Immunity.
Cells and Organs1 Components of the Immune System Learn on your own: Spleen structure and function Mast cells and NK cells Self-Test Questions: A1: allC1:
Immune responses that are inadequately controlled, inappropriately targeted to host tissues, or triggered by commensal microorganisms or usually harmless.
Essentials of Marketing Research William G. Zikmund Chapter 9: Experimental Research.
The Future of Chemical Toxicity Testing in the U.S.
ORGANIZATION OF THE IMMUNE SYSTEM different cell types diffuse communication network between cells ‚signal transduction’ and inhibition similarity to the.
Introduction to Hematology/White blood Cells Laboratory Procedures.
Effector T Cell Subsets, Cytokines
Essentials of Marketing Research William G. Zikmund
Basophils Karen Buckland, Imperial College London, UK
July 17 (MON) 16:30 / Auditorium (1F), PBC
Hypersensitivity reactions
GENERAL IMMUNOLOGY PHT 324
Action: BM0806 Recent Advances in Histamine Receptor H4R Research
The function and mechanism of mast cell in anti-colon cancer immunity
GLEE-ful for sickle cell pain?
Cell Signaling.
Diagnosis and management of anaphylaxis in precision medicine
Fanny Legrand, PhD, PharmD, Amy D. Klion, MD 
Figure 4 Macrophage-targeting antitumour treatment approaches
Histamine H1 receptor antagonist
ERK1/2 antagonize AMPK-dependent regulation of FcεRI-mediated mast cell activation and anaphylaxis  Seung-Lark Hwang, PhD, Yue Lu, PhD, Xian Li, MSc,
Activin A and TGF-β promote TH9 cell–mediated pulmonary allergic pathology  Carla P. Jones, PhD, Lisa G. Gregory, PhD, Benjamin Causton, BSc, Gaynor A.
Evaluation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (Lab 4)
Ayman Grada, MD, Joshua Mervis BS, Vincent Falanga, MD, FACP
Figure 2 Key brain–immune–gut interactions
Host Immune Response to Infection and Cancer: Unexpected Commonalities
Tilo Biedermann, Martin Röcken, José M. Carballido 
The pathophysiology of anaphylaxis
Group 2: Animal models for mast cell research
Volume 37, Issue 5, Pages (November 2012)
Production and Pharmacologic Modulation of the Granulocyte-Associated Allergic Responses to Ovalbumin in Murine Skin Models Induced by Injecting Ovalbumin-
Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell–dependent manner through cysteinyl leukotriene.
Research Techniques Made Simple: Mouse models of atopic dermatitis
Vaccines for Lung Cancer
Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell–mediated allergic inflammation  Yong-Jun Liu, MD, PhD  Journal.
Amb a 1–linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma  Joanna V. Santeliz, MDa, Gary Van.
The future of biologics: Applications for food allergy
Presentation transcript:

Introduction In vivo animal models for Mast cell research: 1.Guinea Pig 2.Humanized Mice 3.Zebrafish Aim: comparison of established versus new in vivo models Group 2: Animal models for mast cell research Trainer: Katerina Tiligada

Aim: to evaluate a combination treatment in an animal model of early allergic reaction in the lung by using the established guinea pig model Background: insufficiency of mouse models due to differences between human and mice MC distribution, mediator release and phenotype

P: Pyrilamine - H 1 antagonist M: Montelukast - cysLT inhibitor I: Indomethacin – COX inhibitor - NSAID Treatment with pyrilamine in combination with montelukast or/and indomethacin reduced EAR

Summary The sensitized guinea pig is a well accepted and validated model for the study of pharmacological approaches related to allergy treatment Limitations of the study Methodological shortcomings (e.g. no dose-response-curve, no justification for the selection of drugs to be investigated) Limited novel information

Background: lack of mice model which reflects human allergy response Aim: To generate a humanized mouse strain that develops human granulocytes and mast cells

Differentiation of myeloid and lymphoid cells in hu-HSC NOG IL-3/GM-Tg mice

Differentiation of myeloid and lymphoid cells in hu-HSC NOG IL-3/GM-Tg mice

Extravasation of Evans blue dye in the skin of hu-HSC NOG IL-3/GM-Tg mice

Summary The first human IL-3 and GM-CSF producing mice able to develop human granulocytes and mast cells A new model which enables the research on human cell in vivo Limitations of the study Lack of cell-cell interactions of the same species origin Mast cells can differentiate depending on the (micro)environment

Zebrafish is a robust model for studying vertebrate hematopoiesis Presence of mast cells, basophils and eosinophils Orthologs of toll-like receptors (TLRs) and myd88 Structural and functional similarities between zebrafish and mammalian MCs Aim: Investigation of the FcεRI-mediated MC response upon stimulation

Release of tryptase is induced by C48/80 and A. salmonicida while being inhibited by ketotifen

Release of tryptase is induced by anti-IgE:DNP complex

Summary Zebrafish represents a potential new model for studying MC-mediated responses in vivo Limitationsof the study Functional studies to support the preliminary findings not conducted Inhibition of the IgE-mediated pathway not investigated Experimental settings are not specific for zebrafish

Overall summary The attempts of calibration & development of suitable models are continuous. Overall, we are slowly getting closer to (patho)physiological relevance Functional and behavioral studies on MCs are being researched in few models, each one being suitable for a limited range of research questions/hypotheses No universal model is available; depending on the question to be answered, acceptable models have to be selected Preliminary data Validated Guinea pig Humanized mice  Zebrafish 

Difficulties in in vivo studies: validation protocols; different markers, triggers, agents, etc Need for harmonization & standardization of the essential protocols/methodologies for validation of novel in vivo models in various species: consideration of strain, gender, age differences/variations; visibility of negative results is essential In vivo drug administration: consideration of strain-related differences, ligand specificity, ligand-directed signaling, threshold/baseline/placebo responses, dose-response curves, selection of the appropriate control drug Inter/intra species cell-cell interaction and immune responses in in vivo models (particularly concerning Tg & humanised models) Comparative definition of mast cell/basophil (rodent models are different from human, including MC/basophil phenotypes & behaviour): need for a (minimal) list of characteristics and comparison between species Group 2: Animal models for mast cell research Trainer: Katerina Tiligada Points following discussion